Sotera Health director Stephanie Geveda resigns; Robert Knauss appointed as Class III director

Sotera Health Co

Stephanie M. Geveda resigned from the Board on October 7, 2022, upon her departure from Warburg Pincus.
Geveda confirmed no disagreement with the Company, management, or Board regarding operations or policies.
Robert B. Knauss, a Warburg Pincus Managing Director, appointed as Class III director effective October 12, 2022.
Appointment made under Stockholders Agreement granting Warburg Pincus director designation rights; Knauss deemed independent per Nasdaq rules.
Knauss will receive standard non-employee director compensation (cash retainer + RSUs) and entered a customary indemnification agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert B. Knauss

Director

SHC · Sotera Health Co

Effective: 2022-10-12
Filed: October 13, 2022, 7:59 PM ET

On October 12, 2022, the Board appointed Robert B. Knauss to serve as a director of the Company, effective October 12, 2022.

Departed

Stephanie M. Geveda

Director

SHC · Sotera Health Co

Effective: 2022-10-07
Successor: Robert B. Knauss
Filed: October 13, 2022, 7:59 PM ET

On October 7, 2022, Stephanie M. Geveda notified Sotera Health Company (the “Company”) of her resignation as a director of the Company, effective October 7, 2022, in connection with her departure from Warburg Pincus LLC (“Warburg Pincus”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Robert B. Knauss was appointed as Director at Sotera Health Co.

Action: appointed
Role: Director

Exact text from the filing

On October 12, 2022, the Board appointed Robert B. Knauss to serve as a director of the Company, effective October 12, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Stephanie M. Geveda resigned as Director at Sotera Health Co.

Action: resigned
Role: Director

Exact text from the filing

On October 7, 2022, Stephanie M. Geveda notified Sotera Health Company (the “Company”) of her resignation as a director of the Company, effective October 7, 2022, in connection with her departure from Warburg Pincus LLC (“Warburg Pincus”).

View on SEC.gov

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001193125-22-262172

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.